1. Home
  2. HRMY vs EVCM Comparison

HRMY vs EVCM Comparison

Compare HRMY & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.59

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo EverCommerce Inc.

EVCM

EverCommerce Inc.

HOLD

Current Price

$12.11

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
EVCM
Founded
2017
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
HRMY
EVCM
Price
$37.59
$12.11
Analyst Decision
Strong Buy
Hold
Analyst Count
9
8
Target Price
$51.33
$11.50
AVG Volume (30 Days)
679.6K
338.0K
Earning Date
02-24-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
50.44
N/A
EPS
3.17
N/A
Revenue
$825,944,000.00
$718,038,000.00
Revenue This Year
$23.11
N/A
Revenue Next Year
$16.15
$5.60
P/E Ratio
$11.60
N/A
Revenue Growth
21.13
22.13
52 Week Low
$25.52
$7.66
52 Week High
$40.93
$14.41

Technical Indicators

Market Signals
Indicator
HRMY
EVCM
Relative Strength Index (RSI) 52.99 59.86
Support Level $35.42 $10.88
Resistance Level $37.79 $12.44
Average True Range (ATR) 1.04 0.61
MACD -0.40 -0.08
Stochastic Oscillator 50.12 60.30

Price Performance

Historical Comparison
HRMY
EVCM

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About EVCM EverCommerce Inc.

EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.

Share on Social Networks: